Bayer to dump $2.26B into manufacturing realignment as it says goodbye to some sites – Endpoints News
Bayer is ready to pour billions more into its pharma manufacturing operations, but with that, it will cut ties with several sites it already owns. Bayer will invest more than $2.26 billion in its pharmaceutical manufacturing over the next three years, as it expands in both Europe and the US. Expansions in Bergkamen, Berlin, Leverkusen,…